Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

Milagritos D. Tapia, Samba O. Sow, B Ndiaye, Khardiata Diallo Mbaye, Aliou Thiongane, Cheikh Ndour, Souleymane Mboup, Julie A. Ake, Babajide Keshinro, Akindiran Akintunde, Thompson Kinge, Guy Vernet, Jean Joël Bigna, Stephen Oguche, Kwadwo Koram, Kwaku Poku Asante, Wayne Hogrefe, Stephan Günther, Abdi Naficy, Iris De Ryck, Muriel Debois, Patricia Bourguignon, Erik Jongert, W R Ballou, Marguerite Koutsoukos, François Roman, Senate Amusu, Leo Ayuk, Catherine Bilong, Owusu Boahen, Makhtar Camara, Fadima Cheick Haidara, D Coly, Siry Dièye, David Dosoo, Melanie Ekedi, Irma Eneida Almeida Dos Santos, Seyram Kaali, Afoke Kokogho, Myron M. Levine, Nick Opoku, Seth Owusu‐Agyei, Simon Pitmang, Fatima Sall, Moussa Seydi, Marcelo B. Sztein, Mathurin Cyrille Tejiokem, Awa Traoré, Marie-Astrid Vernet, Abena Kunadu Yawson